We are live on
!
Find out more
SPPAM
Summit Partners Public Asset Management Portfolio holdings
AUM
$3.72B
1-Year Est. Return
162.29%
This Fund
S&P 500
This Quarter
Est. Return
+11.08%
1 Year Est. Return
+162.29%
3 Year Est. Return
+702.67%
5 Year Est. Return
+1,148.97%
10 Year Est. Return
+22,877.21%
AUM
$286M
AUM Growth
–
Cap. Flow
+$276M
Cap. Flow
% of AUM
96.57%
Top 10 Holdings %
Top 10 Hldgs %
39.46%
Holding
62
New
62
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$15.5M |
| 2 |
Amazon
AMZN
|
+$12.5M |
| 3 |
AGN
Allergan plc
AGN
|
+$11.9M |
| 4 |
Tesla
TSLA
|
+$11.9M |
| 5 |
ABCO
Advisory Board Co
ABCO
|
+$10.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.43% |
| 2 | Consumer Discretionary | 13.04% |
| 3 | Communication Services | 7.98% |
| 4 | Healthcare | 7.95% |
| 5 | Financials | 6.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMPR
51
DELISTED
IMPRIVATA, INC COM
IMPR
| $1.96M | 0.69% |
+120,000
| New | +$1.8M |
|
52
Golar LNG
GLNG
$5B
| $1.87M | 0.65% |
+40,000
| New | +$1.73M |
|
|
DTEA
53
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
| $1.72M | 0.6% |
+80,000
| New | +$1.98M |
|
|
SGYP
54
CALL
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $1.66M | 0.58% |
+200,000
| New | +$969K |
|
|
ESPR
55
CALL
DELISTED
Esperion Therapeutics
ESPR
| $1.64M | 0.57% |
+20,000
| New | +$1.96M |
|
56
CALL
Terex
TEX
$7.36B
| $1.63M | 0.57% |
+70,000
| New | +$1.85M |
|
57
Ideal Power
IPWR
$63.6M
| $1.26M | 0.44% |
+15,000
| New | +$1.37M |
|
|
TWTR
58
CALL
DELISTED
Twitter, Inc.
TWTR
| $1.09M | 0.38% |
+30,000
| New | +$1.23M |
|
|
AVGR
59
DELISTED
Avinger, Inc. Common Stock
AVGR
| $1.04M | 0.36% |
+1
| New | +$1.41M |
|
60
American Superconductor
AMSC
$1.62B
| $964K | 0.34% |
+184,375
| New | +$1.22M |
|
61
CALL
PTC Therapeutics
PTCT
$5.68B
| $963K | 0.34% |
+20,000
| New | +$1.17M |
|
|
ENZY
62
DELISTED
Enzymotec Ltd
ENZY
| $760K | 0.27% |
+90,960
| New | +$835K |
|
Similar funds
OIMU
HA
BCL
OCBCO
CI
CAM
BB
VA
Summit Partners Public Asset Management's Q2 2015 Portfolio in Review
Q2 2015 is the first quarter with a 13F filing on record for Summit Partners Public Asset Management, which disclosed 62 positions worth $286M. Its ten largest holdings account for 39% of the portfolio.
Its largest position is Meta Platforms (Facebook): 190,000 shares worth $16.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, followed by Consumer Discretionary and Communication Services.
- Summit Partners Public Asset Management's largest Q2 2015 buy was Meta Platforms (Facebook): 190,000 shares worth $16.3M.
- Summit Partners Public Asset Management's ten largest holdings make up 39% of its $286M portfolio in Q2 2015.
- Summit Partners Public Asset Management disclosed 62 positions in Q2 2015, its first 13F filing on record.
Based on Summit Partners Public Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.